Latest KFF Health News Stories
Trump’s Deadline On ‘Dreamers’ Reverberates Through Health Industries
From medical students to home health aides, the loss of DACA could deal a blow to the health care workforce, industry leaders suggest.
This Gift Voucher Might Just Get You A Kidney
A retired California judge came up with the idea of donating his kidney to a stranger now to maximize his grandson’s prospects for such a donation later. The idea caught on.
Guess Who Pays The Price When Hospital Giants Hire Your Private Practitioner?
Gobbling up doctors’ independent practices is lucrative for hospital systems — but not necessarily a good deal for the physicians or consumers, critics say. Northern California is a case in point.
Rep. Chris Collins’ Australian Stock Bet Looks Bleaker
Innate Immunotherapeutics, the Australian biotech firm whose largest shareholder is Buffalo, N.Y.-area congressman Chris Collins, said it expects to close after its multiple sclerosis drug failed in trials.
St. Kitts Launches Probe Of Herpes Vaccine Tests On U.S. Patients
After a Kaiser Health News report on an offshore herpes vaccine trial that skirted FDA regulations, St. Kitts and Nevis officials claim they had no knowledge of the testing. An investigation is underway.
Scope Maker Olympus Hit With $6.6 Million Verdict In Superbug Outbreak Case
In the first case of its kind in the U.S., the company was ordered to pay damages to the hospital where a patient died of an infection linked to a contaminated scope. But jurors also found the hospital negligent, and it was ordered to pay the patients’ family $1 million.
In Appalachia, Two Hospital Giants Seek State-Sanctioned Monopoly
Tennessee and Virginia regulators are considering approval of a merger between Mountain States Health Alliance and Wellmont Health System under their state laws. If they allow it, the Federal Trade Commission would be powerless to stop it.
Calif. Hits Nerve By Singling Out Cardiac Surgeons With Higher Patient Death Rates
The controversial practice — done by just a few other states — recently cast a spotlight on some prominent doctors. Supporters say it improves performance; detractors warn it discourages taking on complex cases.
Double-Booked: When Surgeons Operate On Two Patients At Once
Simultaneous surgeries have ignited an impassioned debate in the medical community.
Survivors Of Childhood Diseases Struggle To Find Care As Adults
Once-fatal childhood diseases, like cystic fibrosis, congenital heart disease and sickle cell anemia, now can be survived into adulthood. But when those patients become too old to see pediatricians, it can be difficult for them to find physicians familiar with their conditions.
FDA Ruling On Aussie Biotech Could Boost Congressman’s Investment
Innate Immunotherapeutics, whose largest shareholder is Buffalo-area Rep. Chris Collins, received FDA approval to begin U.S. trials of its drug for treating advanced multiple sclerosis.
Armed with strict guidelines and motivated by sheer urgency, a specialized team of nurses makes the rounds, seeking to thwart the No. 1 killer in U.S. hospitals.
Widow Unleashes Court Fight Against Scope Maker Olympus Over Superbug Outbreak
The Seattle case, the first to reach trial in the U.S., offers possible glimpse into fate of some two dozen lawsuits against manufacturing giant Olympus, accused of failing to address scope contamination linked to numerous deaths. The company faults poor hospital cleaning practices.
Medical Responses To Opioid Addiction Vary By State, Analysis Finds
The study also found that the largest percentage of medical coverage claims related to opioid abuse and dependence nationally come from older patients — those ages 51 to 60.
‘How Long Have I Got, Doc?’ Why Many Cancer Patients Don’t Have Answers
Due to poor doctor-patient communication, most people with advanced cancer don’t know enough about their disease to make vital decisions.
When An Insurer Balks And Treatment Stops
A 22-year old man from Orange County, Calif., alleges in a lawsuit that his health insurer stopped paying for a crucial — and expensive — immunotherapy drug, leading him to become seriously ill. Treatments for patients with similar conditions are increasingly denied or interrupted, experts and patient advocates say.
Molina Healthcare, A Top Obamacare Insurer, Investigates Breach Of Patients’ Data
“It’s unconscionable that such a basic, security 101 flaw could still exist at a major health care provider,” says one cybersecurity expert.
UnitedHealth Doctored Medicare Records, Overbilled U.S. By $1 Billion, Feds Claim
The company, which is the nation’s largest Medicare Advantage operator, denies wrongdoing and argues that the Justice Department “fundamentally misunderstands” how Medicare Advantage works.
Report: Congressional Ethics Office Probing Rep. Chris Collins’ Aussie Investment
The Buffalo News reports the Buffalo, N.Y.-area Republican has drawn inquiries from the Office of Congressional Ethics related to his investment in Australian biotech company Innate Immunotherapeutics.
Grassley, Chaffetz Send Fiery Response To HHS Memo They Say Chills Whistleblowing
The two Republican lawmakers sent a letter to HHS Secretary Tom Price warning him that whistleblowers in HHS could be intimidated into silence by a department memo instructing employees to get clearance before talking with members of Congress and their staffs.
